Blocking two host receptors is better than one: Insights from RSV infection in human respiratory organoids
Open Access
- 5 September 2026
- journal article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 37 (4)
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Dual inhibition of intercellular adhesion molecule-1 and nucleolin reduces RSV infection efficiency in human respiratory organoidsMolecular Therapy Nucleic Acids, 2026
- Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US AdultsJAMA Network Open, 2024
- Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial VirusFrontiers in Cellular and Infection Microbiology, 2022
- Identification of SARS-CoV-2 inhibitors using lung and colonic organoidsNature, 2020
- IGF1R is an entry receptor for respiratory syncytial virusNature, 2020
- Epidermal Growth Factor Receptor Is Essential for Toll-Like Receptor 3 SignalingScience Signaling, 2012
- Identification of nucleolin as a cellular receptor for human respiratory syncytial virusNature Medicine, 2011
- Blocking Intercellular Adhesion Molecule-1 on Human Epithelial Cells Decreases Respiratory Syncytial Virus InfectionBiochemical and Biophysical Research Communications, 2001